Jump Financial’s Janux Therapeutics JANX Stock Holding History

Jump Financial’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.08M	Buy	221,800 +125,116	+129%	+$1.72M	0.05%	490
2025 Q4	$1.33M	Sell	96,684 -83,016	-46%	-$1.95M	0.02%	858
2025 Q3	$4.39M	Sell	179,700 -48,730	-21%	-$1.19M	0.06%	445
2025 Q2	$5.28M	Buy	228,430 +134,400	+143%	+$3.54M	0.06%	397
2025 Q1	$2.54M	Buy	+94,030	New	+$3.54M	0.04%	509
2024 Q3	–	Sell	-18,100	Closed	-$758K	–	1882
2024 Q2	$758K	Buy	18,100 +2,409	+15%	+$113K	0.02%	946
2024 Q1	$591K	Buy	+15,691	New	+$342K	0.02%	1082
2023 Q3	–	Sell	-10,821	Closed	-$128K	–	2050
2023 Q2	$128K	Buy	+10,821	New	+$145K	﹤0.01%	1614

Other funds holding JANX

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return